These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12926596)

  • 1. Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment.
    Martínez-Subiela S; Bernal LJ; Cerón JJ
    Am J Vet Res; 2003 Aug; 64(8):1021-6. PubMed ID: 12926596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate.
    Saridomichelakis MN; Xenoulis PG; Chatzis MK; Kasabalis D; Steiner JM; Suchodolski JS; Petanides T
    Vet Parasitol; 2013 Oct; 197(1-2):22-8. PubMed ID: 23685064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of two treatments on changes in serum acute phase protein concentrations in dogs with clinical leishmaniosis.
    Daza González MA; Fragío Arnold C; Fermín Rodríguez M; Checa R; Montoya A; Portero Fuentes M; Rupérez Noguer C; Martínez Subiela S; Cerón JJ; Miró G
    Vet J; 2019 Mar; 245():22-28. PubMed ID: 30819422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of serum pancreatic lipase immunoreactivity and troponin I concentrations in Leishmania infantum-infected dogs treated with meglumine antimonate.
    Xenoulis PG; Saridomichelakis MN; Chatzis MK; Kasabalis D; Petanides T; Suchodolski JS; Steiner JM
    Vet Parasitol; 2014 Jul; 203(3-4):326-30. PubMed ID: 24813787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum.
    Valladares JE; Riera C; Alberola J; Gállego M; Portús M; Cristòfol C; Franquelo C; Arboix M
    Vet Parasitol; 1998 Feb; 75(1):33-40. PubMed ID: 9566092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
    Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
    Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
    Amusategui I; Sainz A; Tesouro MA
    Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510
    [No Abstract]   [Full Text] [Related]  

  • 8. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
    di Martino L; Mantovani MP; Gradoni L; Gramiccia M; Guandalini S
    Trans R Soc Trop Med Hyg; 1990; 84(4):534-5. PubMed ID: 2091347
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of nephrotoxicity and ototoxicity of aminosidine (paromomycin)-allopurinol combination in dogs with leishmaniosis due to Leishmania infantum: A randomized, blinded, controlled study.
    Kasabalis D; Chatzis MK; Apostolidis K; Xenoulis PG; Buono A; Petanides T; Leontides LS; Polizopoulou ZS; Steiner JM; Suchodolski JS; Saridomichelakis MN
    Exp Parasitol; 2019 Nov; 206():107768. PubMed ID: 31539540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the concentration of anti-Leishmania antibodies in saliva of dogs with clinical leishmaniosis after short-term treatment.
    Cantos-Barreda A; Escribano D; Cerón JJ; Tecles F; Bernal LJ; Martínez-Subiela S
    Vet Parasitol; 2018 Apr; 254():135-141. PubMed ID: 29656998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring the reverse to normal of clinico-pathological findings and the disease free interval time using four different treatment protocols for canine leishmaniosis in an endemic area.
    Paradies P; Sasanelli M; Amato ME; Greco B; De Palo P; Lubas G
    Res Vet Sci; 2012 Oct; 93(2):843-7. PubMed ID: 22296941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of prednisone on haemostasis in leishmaniotic dogs treated with meglumine antimoniate and allopurinol.
    Cortese L; Pelagalli A; Piantedosi D; Mastellone V; Di Loria A; Lombardi P; Ciaramella P; Avallone L
    Vet J; 2008 Sep; 177(3):405-10. PubMed ID: 17629526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol.
    Castro RS; de Amorim IFG; Pereira RA; Silva SM; Pinheiro LJ; Pinto AJW; Azevedo EG; Demicheli C; Caliari MMV; Mosser DM; Michalick MSM; Frezard FJG; Tafuri WL
    Vet Parasitol; 2018 Jan; 250():22-29. PubMed ID: 29329619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of therapy on haemostasis in dogs infected with Leishmania infantum, Ehrlichia canis, or both combined.
    Cortese L; Pelagalli A; Piantedosi D; Cestaro A; Di Loria A; Lombardi P; Avallone L; Ciaramella P
    Vet Rec; 2009 Apr; 164(14):433-4. PubMed ID: 19346544
    [No Abstract]   [Full Text] [Related]  

  • 15. Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol.
    Manna L; Reale S; Vitale F; Picillo E; Pavone LM; Gravino AE
    Vet J; 2008 Aug; 177(2):279-82. PubMed ID: 17553711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.
    Solano-Gallego L; Riera C; Roura X; Iniesta L; Gallego M; Valladares JE; Fisa R; Castillejo S; Alberola J; Ferrer L; Arboix M; Portús M
    Vet Parasitol; 2001 Apr; 96(4):265-76. PubMed ID: 11267753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Efficacy of a Mixed Formulation of Conventional and PEGylated Liposomes Containing Meglumine Antimoniate, Combined with Allopurinol, in Dogs Naturally Infected with Leishmania infantum.
    Dos Santos CCP; Ramos GS; De Paula RC; Faria KF; Moreira POL; Pereira RA; Melo MN; Tafuri WL; Demicheli C; Ribeiro RR; Azevedo EG; Do Monte-Neto R; Da Silva SM; Frézard F
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32284386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tongue nodules in canine leishmaniosis--a case report.
    Viegas C; Requicha J; Albuquerque C; Sargo T; Machado J; Dias I; Pires MA; Campino L; Cardoso L
    Parasit Vectors; 2012 Jun; 5():120. PubMed ID: 22704596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early reduction of Leishmania infantum-specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease.
    Solano-Gallego L; Di Filippo L; Ordeix L; Planellas M; Roura X; Altet L; Martínez-Orellana P; Montserrat S
    Parasit Vectors; 2016 May; 9(1):235. PubMed ID: 27160317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, blinded, controlled clinical trial comparing the efficacy of aminosidine (paromomycin)-allopurinol combination with the efficacy of meglumine antimoniate-allopurinol combination for the treatment of canine leishmaniosis due to Leishmania infantum.
    Kasabalis D; Chatzis MK; Apostolidis K; Petanides T; Athanasiou LV; Xenoulis PG; Mataragka A; Ikonomopoulos J; Leontides LS; Saridomichelakis MN
    Exp Parasitol; 2020 Jul; 214():107903. PubMed ID: 32360142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.